Daito Pharmaceutical Co (TSE:4577) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
82 GF Score
Price 円1,333.00
GF Value 円1,298.02
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Daito Pharmaceutical Co  (TSE:4577) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Daito Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms


Daito Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Daito Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Daito Pharmaceutical Co Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 0.89 0.85 0.69 0.78

Daito Pharmaceutical Co Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.86 0.90 1.00 0.80

TSE:4577 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Daito Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daito Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daito Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Daito Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TSE:4577
82GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daito Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Daito Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in May. 2026 is calculated as:

For example, Daito Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in May. 2026 was:

Adj_Book=Book Value per Share/CPI of May. 2026 (Change)*Current CPI (May. 2026)
=1841.718/113.5000*113.5000
=1,841.718

Current CPI (May. 2026) = 113.5000.

Daito Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201608 858.585 97.900 995.397
201611 888.908 98.600 1,023.236
201702 916.865 98.100 1,060.797
201705 937.626 98.600 1,079.316
201708 955.698 98.500 1,101.236
201711 992.618 99.100 1,136.853
201802 1,014.537 99.500 1,157.286
201805 1,035.057 99.300 1,183.071
201808 1,055.760 99.800 1,200.689
201811 1,088.006 100.000 1,234.887
201902 1,107.295 99.700 1,260.562
201905 1,138.731 100.000 1,292.460
201908 1,161.392 100.000 1,318.180
201911 1,205.612 100.500 1,361.562
202002 1,237.342 100.300 1,400.183
202005 1,272.655 100.100 1,443.020
202008 1,310.589 100.100 1,486.032
202011 1,347.728 99.500 1,537.358
202102 1,377.332 99.800 1,566.405
202105 1,389.382 99.400 1,586.467
202108 1,436.627 99.700 1,635.478
202111 1,468.375 100.100 1,664.941
202202 1,498.855 100.700 1,689.375
202205 1,516.641 101.800 1,690.950
202208 1,536.502 102.700 1,698.082
202211 1,567.101 103.900 1,711.896
202302 1,577.259 104.000 1,721.336
202305 1,612.698 105.100 1,741.591
202308 1,624.124 105.900 1,740.681
202311 1,649.053 106.900 1,750.865
202402 1,663.482 106.900 1,766.185
202405 1,708.770 108.100 1,794.129
202408 1,702.763 109.100 1,771.435
202411 1,700.769 110.000 1,754.884
202502 1,704.065 110.800 1,745.590
202505 1,736.371 111.800 1,762.774
202508 1,741.311 112.100 1,763.058
202511 1,764.832 113.200 1,769.509
202602 1,794.551 112.200 1,815.343
202605 1,841.718 113.500 1,841.718

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be overvalued. The current stock price of 円1,333.00 is trading 2.7% above its estimated GF Value™ of 円1,298.02. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: 円1,298.02 vs. price of 円1,333.00 (2.7% above fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
82GF Score

Get the complete analysis for TSE:4577

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,333.00
Price
円1,298.02
GF Value